Rationale: Aberrant prefrontal-hippocampal (PFC-HC) connectivity is disrupted in several psychiatric and at-risk conditions. Advances in rodent functional imaging have opened the possibility that this phenotype could serve as a translational imaging marker for psychiatric research. Recent evidence from functional magnetic resonance imaging (fMRI) studies has indicated an increase in PFC-HC coupling during working-memory tasks in both schizophrenic patients and at-risk populations, in contrast to a decrease in resting-state PFC-HC connectivity. Acute ketamine challenge is widely used in both humans and rats as a pharmacological model to study the mechanisms of N-methyl-D-aspartate (NMDA) receptor hypofunction in the context of psychiatric disorders.

Objectives: We aimed to establish whether acute ketamine challenge has consistent effects in rats and humans by investigating resting-state fMRI PFC-HC connectivity and thus to corroborate its potential utility as a translational probe.

Methods: Twenty-four healthy human subjects (12 females, mean age 25 years) received intravenous doses of either saline (placebo) or ketamine (0.5 mg/kg body weight). Eighteen Sprague-Dawley male rats received either saline or ketamine (25 mg/kg). Resting-state fMRI measurements took place after injections, and the data were analyzed for PFC-HC functional connectivity.

Results: In both species, ketamine induced a robust increase in PFC-HC coupling, in contrast to findings in chronic schizophrenia.

Conclusions: This translational comparison demonstrates a cross-species consistency in pharmacological effect and elucidates ketamine-induced alterations in PFC-HC coupling, a phenotype often disrupted in pathological conditions, which may give clue to understanding of psychiatric disorders and their onset, and help in the development of new treatments.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-015-4022-yDOI Listing

Publication Analysis

Top Keywords

acute ketamine
12
ketamine challenge
12
pfc-hc connectivity
12
pfc-hc coupling
12
humans rats
8
increase pfc-hc
8
resting-state fmri
8
pfc-hc
7
ketamine
5
challenge increases
4

Similar Publications

The Impact of Ketamine on Outcomes in Acute Pain Management: An Umbrella Review.

J Clin Med

December 2024

Department of Anaesthesiology and Intensive Care, Hospital Clìnico Universitario de Valencia, University of Valencia, 46003 Valencia, Spain.

: Ketamine offers effective pain relief with fewer side effects than traditional analgesics, making it a promising alternative for acute pain treatment. However, further research is needed to fully assess its role in perioperative care. This umbrella review aimed to compile the highest-quality evidence available regarding the application of ketamine in managing acute pain.

View Article and Find Full Text PDF

Objectives: While neuropsychological effects of conventional antidepressants are well-documented, more research is needed for rapid-acting antidepressants. This study examines the effects of esketamine on emotion processing and cognitive functioning, both acutely and sub-chronically.

Methods: Eighteen treatment-resistant depression (TRD) patients received repeated intravenous esketamine infusions.

View Article and Find Full Text PDF

Pain Management in Brugada Syndrome: A Case Report and Review.

A A Pract

January 2025

Division of Anaesthesiology and Perioperative Medicine, Department of Pain Medicine, Singapore General Hospital, Singapore.

Article Synopsis
  • Brugada syndrome is a rare condition that elevates the risk of serious heart arrhythmias, with limited guidance on pain management for these patients.
  • A case study of a young woman with the syndrome highlights the use of ropivacaine peripheral nerve infusion and intravenous ketamine for managing her acute-on-chronic pain in the left upper limb.
  • The approach included a multimodal analgesia strategy with neuropathic agents and opioids, aiming to improve safe pain management practices for those with Brugada syndrome.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between pain scores and white blood cell counts in children with mucositis due to immunosuppression from cancer treatments.
  • The research involved 50 children, measuring pain relief alongside changes in white blood cell counts and the effects of opioid and ketamine analgesia.
  • Findings revealed a significant delay of about 0.29 days for pain to respond to increasing white blood cell counts, highlighting the dominance of biological recovery over analgesic intervention in pain management.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!